VALN and VLA Related Headlines

Go Back

May 5, 2026 11:45AM Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
Mar 23, 2026 06:45AM Pfizer and Valneva's Lyme disease vaccine shows over 70% efficacy
Mar 23, 2026 06:45AM Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Mar 18, 2026 08:00AM Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
Jan 19, 2026 12:00PM Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Oct 27, 2025 12:45PM Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Jul 29, 2025 10:00AM AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

VALN and VLA Related Press Releases

Go Back

May 5, 2026 11:45AM Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026
Mar 23, 2026 06:45AM Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Mar 18, 2026 08:00AM Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
Jan 19, 2026 12:00PM Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
Oct 27, 2025 12:45PM Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
Jul 29, 2025 10:00AM AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

VALN and VLA Related SEC Filings

Go Back

Jun 1, 2026 10:00AM Form 6-K Valneva SE For: Dec 31
May 13, 2026 04:49PM Form 6-K Valneva SE For: Mar 31
Mar 18, 2026 11:22AM Form 6-K Valneva SE For: Dec 31
Mar 17, 2026 04:37PM Form 20-F Valneva SE For: Dec 31
Mar 10, 2026 04:01PM Form SCHEDULE 13D/A Valneva SE Filed by: Bpifrance Participations SA
Mar 9, 2026 12:51PM Form 6-K Valneva SE For: Dec 31
Mar 2, 2026 11:51AM Form 6-K Valneva SE For: Dec 31
Feb 19, 2026 06:19AM Form 6-K Valneva SE For: Dec 31
Feb 13, 2026 11:52AM Form 6-K Valneva SE For: Dec 31
Feb 3, 2026 09:18AM Form 6-K Valneva SE For: Dec 31
Jan 20, 2026 09:50AM Form 6-K Valneva SE For: Dec 31
Jan 9, 2026 10:55AM Form 6-K Valneva SE For: Dec 31
Dec 31, 2025 11:54AM Form 6-K Valneva SE For: Dec 31
Dec 11, 2025 06:26AM Form 6-K Valneva SE For: Dec 31
Nov 28, 2025 06:44AM Form 6-K Valneva SE For: Dec 31
Nov 26, 2025 08:21AM Form 6-K Valneva SE For: Dec 31
Nov 20, 2025 06:04AM Form 6-K Valneva SE For: Sep 30
Nov 4, 2025 06:28AM Form 6-K Valneva SE For: Dec 31
Oct 6, 2025 01:11PM Form 6-K/A Valneva SE For: Dec 31
Oct 6, 2025 12:51PM Form 6-K Valneva SE For: Dec 31
Oct 6, 2025 12:03PM Form 6-K Valneva SE For: Dec 31
Sep 5, 2025 04:16PM Form SCHEDULE 13D/A Valneva SE Filed by: Bpifrance Participations SA
Sep 3, 2025 08:26AM Form 6-K Valneva SE For: Dec 31
Aug 25, 2025 06:24AM Form 6-K Valneva SE For: Dec 31
Aug 18, 2025 09:45AM Form 6-K Valneva SE For: Dec 31
Aug 12, 2025 09:45AM Form 6-K Valneva SE For: Jun 30
Aug 7, 2025 08:26AM Form 6-K Valneva SE For: Dec 31
Jul 11, 2025 02:04PM Form 6-K Valneva SE For: Dec 31
Jun 26, 2025 07:31AM Form 6-K Valneva SE For: Dec 31
Jun 25, 2025 01:35PM Form 6-K Valneva SE For: Dec 31
Jun 5, 2025 04:24PM Form 6-K Valneva SE For: Dec 31
Jun 4, 2025 06:08AM Form 6-K Valneva SE For: Dec 31